[Prevention of cardiovascular diseases and patient compliance: limiting factors and proposals].
Despite epidemiological evidence in favour of cardiovascular prevention, many surveys show that only a minority of patients with coronary heart disease are receiving hypolipidemic therapy. The compliance is the neglected issue in preventive cardiology, for many reasons. The patients are reluctant to change their long lasting nutritional and smoking habits. The physicians are more motivated by acute care and are not trained in preventive medicine. Moreover there is too often a lack of interface between specialists and GP. To improve compliance, it is necessary to give clear instructions and tailored regimens. The treatment must be monitored and the follow up organised. Last but not least, the reimbursement of hypolipidemic drugs should be adapted to Evidence Based Medicine.